✦ LIBER ✦

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

✍ Scribed by Bougnoux, P; Hajjaji, N; Ferrasson, M N; Giraudeau, B; Couet, C; Le Floch, O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of doxorubicin and triflu

✍ G. T. Budd; R. M. Bukowski; A. Lichtin; L. Bauer; P. Kirk; R. Ganapathi 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 361 KB

A phase II trial of docetaxel (Taxotere®

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Phase II trial of 10-EDAM in the treatme

✍ Garth A. Beinart; Ana M. Gonzalez-Angulo; Kristine Broglio; Debbie Frye; Ronald 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 273 KB

Pharmacokinetics and clinical impact of

✍ Linda M. Sutton; Marc A. Warmuth; William P. Petros; Eric P. Winer 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

A phase II trial of imatinib mesylate mo

✍ Shanu Modi; Andrew D. Seidman; Maura Dickler; Mark Moasser; Gabriella D’Andrea; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 255 KB

Multicentric phase II trial of gemcitabi

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB